4-bromo-1-(difluoromethyl)-1H-imidazole | 1216310-31-4

• 分子结构分类: 有机化合物 - 有机卤素化合物 - 芳基卤化物
• 英文名称: 4-bromo-1-(difluoromethyl)-1H-imidazole
• 英文别名: 4-bromo-1-(difluoromethyl)imidazole
• CAS: 1216310-31-4
• 化学式: C₄H₃BrF₂N₂
• 分子量: 196.982
• InChiKey: BIZYMGHNRLSEAQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  9
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  17.8
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  2,4,5-tribromo-1-(difluoromethyl)-1H-imidazole 在 甲基溴化镁 作用下， 以 四氢呋喃 为溶剂， 以97 %的产率得到4-bromo-1-(difluoromethyl)-1H-imidazole
  参考文献：
  名称：

  CN115215803

  摘要：

  公开号：

文献信息

• [EN] HETEROARYL SYK INHIBITORS<br/>[FR] INHIBITEURS DE SYK DE TYPE HÉTÉROARYLE
  申请人：BOEHRINGER INGELHEIM INT

  公开号：WO2015140054A1

  公开（公告）日：2015-09-24

  The invention relates to new substituted heteroarylsof formula (1) wherein A is selected from the group consisting of N and CH, D is selected from the group consisting of S and O, E is C, T is C, G is C, and wherein each of the broken (dotted) double bonds in ring 1 are selected from either a single bond or a double bond under the proviso that all single and double bonds of ring 1 are arranged in such a way that they all form together with ring 2 an aromatic ring system, and wherein R1, M and R3 are defined according to claim 1, and to the above compounds for the treatment of a disease selected from the group consisting of asthma, COPD, allergic rhinitis, allergic dermatitis, lupus erythematodes, lupus nephritis and rheumatoid arthritis.

  该发明涉及新的取代杂环芳基的化合物，其化学式为（1），其中A选自N和CH组成的群，D选自S和O组成的群，E为C，T为C，G为C，环1中的每个断裂（虚线）双键选自单键或双键，条件是环1的所有单键和双键排列方式使它们与环2一起形成芳香环系统，R1、M和R3根据权利要求1定义，以及上述化合物用于治疗从哮喘、慢性阻塞性肺病、过敏性鼻炎、过敏性皮炎、红斑狼疮、红斑狼疮性肾炎和类风湿性关节炎等疾病。
• N-Difluoromethylation of monosubstituted polydentate azoles
  作者：Kirill I. Petko、Taras M. Sokolenko、Andrey A. Filatov、Vitaliy V. Polovinko、Eduard B. Rusanov、Vadim A. Dudko、Yurii L. Yagupolskii

  DOI：10.1007/s10593-019-02465-x

  日期：2019.5

  This study was focused on N-difluoromethylation of monosubstituted polydentate azoles (imidazoles, pyrazoles, and 1,2,4-triazoles) having two or three reactive sites. The substituent effects and role of reaction conditions in determining the product ratio was explored. In the majority of cases, the obtained mixtures of isomers were separated. The target products containing halogen substituents, amino

  这项研究集中在具有两个或三个反应位点的单取代多齿唑（咪唑，吡唑和1,2,4-三唑）的N-二氟甲基化上。探索了取代基效应和反应条件在确定产物比率中的作用。在大多数情况下，分离得到的异构体混合物。环中含有卤素取代基，氨基或羧基的目标产物可作为合成实际有用产物的有价值的起始化合物。
• HETEROARYL SYK INHIBITORS
  申请人：BOEHRINGER INGELHEIM INTERNATIONAL GMBH

  公开号：US20160244446A1

  公开（公告）日：2016-08-25

  The invention relates to new substituted heteroaryls of formula (1), wherein A is selected from the group consisting of N and CH, D is CH, E is selected from the group consisting of C and N, T is C, G is selected from the group consisting of C and N, and wherein each of the broken (dotted) double bonds in ring 1 are selected from either a single bond or a double bond under the proviso that all single and double bonds of ring 1 are arranged in such a way that they all form together with ring 2 an aromatic ring system, and wherein R 1 , M and R 3 are defined according to claim 1 , and to the above compounds for the treatment of a disease selected from the group consisting of asthma, COPD, allergic rhinitis, allergic dermatitis, lupus erythematodes, lupus nephritis and rheumatoid arthritis.

  本发明涉及一种新的式子（1）的取代杂环芳基，其中A选择自N和CH组成的群体，D为CH，E选择自C和N组成的群体，T为C，G选择自C和N组成的群体，其中在环1中的所有破碎（虚线）双键选择为单键或双键，前提是环1的所有单键和双键排列在一起，与环2一起形成一个芳香环系统，其中R1、M和R3根据权利要求所定义，以及上述化合物用于治疗哮喘、COPD、过敏性鼻炎、过敏性皮炎、红斑狼疮、狼疮性肾炎和类风湿性关节炎等疾病。
• CN115215803
  申请人：——

  公开号：——

  公开（公告）日：——